CogniCann

CogniCann

Products

Information

CogniCann® is an Investigational Medicinal Product based on two APIs, low CBD and high THC, designed to be used for symptoms associated with Dementia and Alzheimer's. A Phase II, randomized, double-blind cross-over, placebo-controlled clinical study designed to evaluate the clinical efficacy of the CogniCann® and determine the therapeutic individual dose-response​. Available in Australia through the special Access Scheme (SAS)
Argent BioPharma ltd7F78Argent BioPharma, an innovative drug discovery company listed on the London Stock Exchange, is enhancing its commitment to accessible medical treatments with advancements in poly pharmacology and nanotechnology. As a clinical-stage, revenue-generating biopharmaceutical company, we focus on addressing unmet medical needs through cutting-edge research and development. At Argent Biopharma, we provide comprehensive Contract Manufacturing Organization (CMO) services for non-sterile oral liquid dosage forms. With a GMP certified facility and fully automated production.

Join the event!